Neuroendocrine carcinomas of the lung a critical analysis

American Journal of Clinical Pathology

Volumn 131, Issue 2, 2009, Pages 206-221

  Moran, Cesar A ^a,e   Suster, Saul ^b   Coppola, Domenico ^c   Wick, Mark R ^d  

^a UNIVERSITY OF TEXAS   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Classification; Lung neoplasms; Neuroendocrine carcinoma; Nomenclature

Indexed keywords

CARCINOID; CONTINUING EDUCATION; HISTOGENESIS; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG CARCINOMA; LUNG SMALL CELL CANCER; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; REVIEW; TRANSBRONCHIAL BIOPSY; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; WORLD HEALTH ORGANIZATION; CARCINOMA; CHEMISTRY; DIAGNOSTIC ERROR; LUNG TUMOR; NOMENCLATURE; PATHOLOGY;

TUMOR MARKER;

CARCINOMA, NEUROENDOCRINE; DIAGNOSTIC ERRORS; HUMANS; LUNG NEOPLASMS; TERMINOLOGY AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 58849161896     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP9H1OTMUCSKQW     Document Type: Review

References (104)

1. Muller NL, Miller RR. Neuroendocrine carcinomas of the lung. Semin Roentgenol. 1990;25:96-104.
2. Travis WD, Brambilla E, Muller-Hermelink HK, et al, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumours.
3. Cerilli LA, Ritter J, Mills SE, et al. Neuroendocrine neoplasms of the lung. Am J Clin Pathol. 2001;116(suppl 1):S65-S96.
4. Flieder DB. Neuroendocrine tumors of the lung: recent developments in histopathology. Curr Opin Pulm Med. 2002;8:275-280.
5. Oberndorfer S. Karzinoide Tumoren des Dunndarms. Frankfurter Zeischrift Pathol. 1907:425-432.
6. Bunting CH. Multiple primary carcinomata of the ileum. Johns Hopkins Hosp Bull. 1904;165:389-394.
7. Gosset A, Masson P. Tumeurs endocrines de l'appendice. Presse Med. 1914;25:237-240.
8. Kinney FJ, Kovarik JL. Bone formation in bronchial adenoma. Am J Clin Pathol. 1965;44:52-56.
9. Heimburger IL, Kilman JW, Battersby JS. Peripheral bronchial adenomas. J Thorac Cardiovasc Surg. 1966;52:542-549.
10. Gmelich JT, Bensch KG, Liebow AA. Cells of Kultschitzky type in bronchioles and their relation to the origin of peripheral carcinoid tumor. Lab Invest. 1967;17:88-98.
11. Hausman DH, Weimann R. Pulmonary tumorlet with hilar lymph node metastasis. Cancer. 1967;20:1515-1519.
12. Azzopardi JG. Oat cell carcinoma of the bronchus. J Pathol Bacteriol. 1959;78:513-519.
13. Kato Y, Ferguson TB, Bennett DE, et al. Oat cell carcinoma of the lung: a review of 138 cases. Cancer. 1969;23:517-524.
14. Gould VE, Memoli VA, Dardi LE. Multidirectional differentiation in human epithelial cancers. J Submicrosc Cytol. 1981;13:97-115.
15. Gould VE. Histogenesis and differentiation: a re-evaluation of these concepts as criteria for the classification of tumors. Hum Pathol. 1986;17:212-215.
16. Sheppard MN. Neuroendocrine differentiation in lung tumours. Thorax. 1991;46:843-850.
17. Brambilla E, Lantuejoul S, Sturm N. Divergent differentiation in neuroendocrine tumors. Semin Diagn Pathol. 2000;17:138-148.
18. Gould VE. Neuroendocrinomas and neuroendocrine carcinomas: APUD cell system neoplasms and their aberrant secretory activities. Pathol Annu. 1977;12:33-62.
19. Gould VE, Linnoila RI, Memoli VA, et al. Neuroendocrine cells and neuroendocrine neoplasms of the lung. Pathol Annu. 1983;18(pt 1):287-330.
20. Warren WH, Gould VE, Faber LP, et al. Neuroendocrine neoplasms of the bronchopulmonary tract. J Thorac Cardiovasc Surg. 1985;89:819-825.
21. Paladugu RR, Benfield JR, Pak HY, et al. Bronchopulmonary Kultchitzky cell carcinomas: a new classification scheme for typical and atypical carcinoids. Cancer. 1985;55:1303-1311.
22. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 1972;64:413-421.
23. Mills SE, Cooper PH, Walker AN, et al. Atypical carcinoid tumor of the lung. Am J Surg Pathol. 1982;6:643-654.
24. Valli M, Fabris GA, Dewar A, et al. Atypical carcinoid tumour of the lung: a study of 33 cases with prognostic features. Histopathology. 1994;24:363-369.
25. Grote TH, Macon WR, Davis B, et al. Atypical carcinoid of the lung: a distinct clinicopathologic entity. Chest. 1988;93:370-375.
26. Capella C, Heitz PU, Hofler H, et al. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 1994;425:547-560.
27. Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15:529-553.
28. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998;22:934-944.
29. Travis WD, Gal AA, Colby TV, et al. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol. 1998;29:272-279.
30. Huang Q, Muzitansky A, Mark EJ. Pulmonary neuroendocrine carcinomas: a review of 234 cases and statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification. Arch Pathol Lab Med. 2002;126:545-553.
31. Ricci C, Patrassi N, Massa R, et al. Carcinoid syndrome in bronchial adenoma. Am J Surg. 1973;126:671-677.
32. Sklar JL, Churg A, Bensch KG. Oncocytic carcinoid tumor of the lung. Am J Surg Pathol. 1980;4:287-292.
33. Cebelin MS. Melanocytic bronchial carcinoid tumor. Cancer. 1980;46:1843-1848.
34. Wise WS, Bonder D, Aikawa M, et al. Carcinoid tumor of lung with varied histology. Am J Surg Pathol. 1982;6:261-267.
35. Grazer R, Jacobs SB, Lucas P. Melanin-containing peripheral carcinoid of the lung. Am J Surg Pathol. 1982;6:73-78.
36. Gal AA, Koss MN, Hochholzer L, et al. Pigmented pulmonary carcinoid tumor. Arch Pathol Lab Med. 1993;117:832-836.
37. Tsutsumi Y, Yazaki K. Atypical carcinoid tumor of the lung, associated with giant-cell transformation in bone metastasis. Acta Pathol Jpn. 1990;40:609-615.
38. Memoli VA. Well-differentiated neuroendocrine carcinoma: a designation comes of age [editorial]. Chest. 1991;10:892.
39. Sturm N, Rossi G, Lantuejoul S, et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol. 2002;33:175-182.
40. Costes V, Marty-Ane C, Picot MC, et al. Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and Ki-67-labeling study. Hum Pathol. 1995;26:740-745.
41. Walch AK, Zitzelsberger HF, Bauchinger M, et al. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol. 1998;153:1089-1098.
42. Wilkins EW, Grillo HC, Moncure AC, et al. Changing times in surgical management of bronchopulmonary carcinoid tumor. Ann Thorac Surg. 1984;38:339-344.
43. Schreurs JM, Westermann JJ, van den Bosch JMM, et al. A twenty-five-year follow-up of ninety-three resected typical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 1992;104:1470-1475.
44. Nicholson SA, Beasley MB, Brambilla E, et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol. 2002;26:1184-1197.
45. Zakowski MF. Pathology of small cell carcinoma of the lung. Semin Oncol. 2003;30:3-8.
46. Vollmer RT, Birch R, Ogden L, et al. Subclassification of small cell cancer of the lung: the Southern Cancer Study Group experience. Hum Pathol. 1985;16:247-252.
47. Hirsch FR, Matthews MJ, Aisner S, et al. Histopathologic classification of small cell lung cancer: changing concepts and terminology. Cancer. 1988;62:973-977.
48. Warren WH, Memoli VA, Jordan AG, et al. Reevaluation of pulmonary neoplasms resected as small cell carcinomas. Cancer. 1990;65:1003-1010.
49. Guinee DG, Fishback NF, Koss MN, et al. The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open lung biopsies. Cancer. 1994;102:406-414.
50. Warren WH, Gould VE. Differential diagnosis of small cell neuroendocrine carcinoma of the lung. Chest Surg Clin N Am. 1997;7:49-63.
51. Spiegelman D, Maurer LH, Ware JH, et al. Prognostic factors in small cell carcinoma of the lung: an analysis of 1,521 patients. J Clin Oncol. 1989;7:344-354.
52. Mooi WJ, Dewar A, Springall D, et al. Non-small cell lung carcinomas with neuroendocrine features: a light microscopic, immunohistochemical and ultrastructural study of 11 cases. Histopathology. 1988;13:329-337.
53. Dresler CM, Ritter JH, Patterson GA, et al. Clinical- pathological analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg. 1997;63:180-185.
54. Yang YJ, Steele CT, Ou XL, et al. Diagnosis of high-grade pulmonary neuroendocrine carcinoma by fine-needle aspiration biopsy: nonsmall-cell or small-cell type? Diagn Cytopathol. 2001;25:292-300.
55. Marchevsky AM, Gal AA, Shah S, et al. Morphometry confirms the presence of considerable nuclear size overlap between "small cells" and "large cells" in high-grade pulmonary neuroendocrine neoplasms. Am J Clin Pathol. 2001;116:466-472.
56. Iyoda A, Hiroshima K, Toyozaki T, et al. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer. 2001;91:1992-2000.
57. Zacharias J, Nicholson AG, Ladas GP, et al. Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection. Ann Thorac Surg. 2003;75:348-352.
58. Takei H, Asamura H, Maeshima A, et al. Large cell neuro- endocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg. 2002;124:285-292.
59. Mazieres J, Daste G, Molinier L, et al. Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases. Lung Cancer. 2002;37:287-292.
60. Jung K-J, Lee KS, Han J, et al. Large cell neuroendocrine carcinoma of the lung: clinical, CT, and pathological findings in 11 patients. J Thorac Imaging. 2001;16:156-162.
61. Filosso PL, Ruffini E, Oliaro A, et al. Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide. J Thorac Cardiovasc Surg. 2005;129:819-824.
62. Hage R Seldenrijk K, de Bruin P, et al. Pulmonary large-cell neuroendocrine carcinoma (LCNEC). Eur J Cardiothorac Surg. 2003;23:457-460.
63. Yamanishi M, Takeuchi S, Kurashina R, et al. High survival rate of 6 cases of pulmonary large cell neuroendocrine carcinoma formerly classified as small cell carcinoma. J Nippon Med Sch. 2001;68:335-339.
64. Doddoli C, Barlesi F, Chetaille B, et al. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery. Ann Thorac Surg. 2004;77:1168-1172.
65. Paci M, Cavazza A, Annessi V, et al. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg. 2004;77:1163-1167.
66. Jiang S-X, Kameya T, Shoji M, et al. Neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Am J Surg Pathol. 1998;22:526-537.
67. Skuladottir H, Hirsch FR, Hansen HH, et al. Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes: a population-based study in Denmark. Lung Cancer. 2002;37:127-135.
68. Cooper WA, Thourani VH, Gal AA, et al. The surgical spectrum of pulmonary neuroendocrine neoplasms. Chest. 2001;119:14-18.
69. Veronesi G, Morandi U, Alloisio M, et al. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Lung Cancer. 2006;53:111-115.
70. Masuya D, Liu D, Ishikawa S, et al. Large cell carcinoma with neuroendocrine morphology of the lung. Jpn J Thorac Cardiovasc Surg. 2006;54:31-34.
71. Battafarano RJ, Fernandez FG, Ritter J, et al. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;130:166-172.
72. Iyoda A, Hiroshima K, Baba M, et al. Pulmonary large cell carcinoma with neuroendocrine features are high-grade neuroendocrine tumors. Ann Thorac Surg. 2002;73:1049-1054.
73. Peng W-X, Sano T, Oyama T, et al. Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma. Lung Cancer. 2005;47:225-233.
74. Garcia-Yuste M, Matilla JM, Alvarez-Gago T, et al. Prognostic factors in neuroendocrine lung tumors: a Spanish multicenter study. Ann Thorac Surg. 2000;70:258-263.
75. Iyoda A, Hiroshima K, Moriya Y, et al. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma. J Thorac Cardiovasc Surg. 2006;132:312-315.
76. Hiroshima K, Iyoda A, Shida T, et al. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis. Mod Pathol. 2006;19:1358-1368.
77. Nitadori J, Ishii G, Tsuta K, et al. Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel. Am J Clin Pathol. 2006;125:682-692.
78. Howe MC, Chapman A, Kerr K, et al. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology. 2004;46:195-201.
79. Carey FA, Save VE. Neuroendocrine differentiation in lung cancer. J Pathol. 1997;182:9-10.
80. Wertzel H, Grahmann PR, Bansbach S, et al. Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression. Eur J Cardiothorac Surg. 1997;12:698-702.
81. Jensen SM, Gazdar AF, Cuttitta F, et al. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Cancer Res. 1990;50:6068-6074.
82. Burnett HE, Zakhour HD, Walker C. Neuroendocrine and epithelial markers in diagnostic bronchial lung cancer biopsy specimens. Eur J Cancer. 1992;28A:853-855.
83. Ionescu DN, Treaba D, Gilks CB, et al. Nonsmall cell lung carcinoma with neuroendocrine differentiation: an entity of no clinical or prognostic significance. Am J Surg Pathol. 2007;31:26-32.
84. Hiroshima K, Iyoda A, Shibuya K, et al. Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung. Ann Thorac Surg. 2002;73:1732-1735.
85. Souhami RL. Neuroendocrine phenotype, chemosensitivity and prognosis in adenocarcinoma of the lung [editorial]. Ann Oncol. 1991;2:323-324.
86. Iyoda A, Hiroshima K, Toyozaki T, et al. Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features. Cancer. 2001;92:1108-1112.
87. Brambilla E, Moro D, Veale D, et al. Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol. 1992;23:993-1003.
88. Lyda MH, Weiss LM. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Hum Pathol. 2000;331:980-987.
89. McDowell EM, Trump BF. Pulmonary small cell carcinoma showing tripartite differentiation in individual cells. Hum Pathol. 1981;12:286-294.
90. Tsubota YT, Kawaguchi T, Hoso T, et al. A combined small cell and spindle cell carcinoma of the lung: report of a unique case with immunohistochemical and ultrastructural studies. Am J Surg Pathol. 1992;16:1008-1115.
91. Adelstein DJ, Tomashefski JF, Snow NJ, et al. Mixed small cell and non-small cell lung cancer. Chest. 1986;89:699-704.
92. Radice PA, Matthews MJ, Ihde DC, et al. The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes. Cancer. 1982;50:2894-2902.
93. Ruffini E, Rena O, Oliaro A, et al. Lung tumors with mixed histologic pattern: clinico-pathologic characteristics and prognostic significance. Eur J Cardiothorac Surg. 2002;22:701-707.
94. Ullmann R, Petzmann S, Sharma A, et al. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung. Hum Pathol. 2001;32:1059-1063.
95. Jones MH, Virtanen C, Honjoh D, et al. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small cell and large cell neuroendocrine carcinomas identified by gene expression profiles. Lancet. 2004;363:775-781.
96. Sampietro G, Tomasic G, Collini P, et al. Gene product immunophenotyping of neuroendocrine lung tumors. Appl Immunohistochem Mol Morphol. 2000;8:49-56.
97. Anbazhagan R, Tihan T, Bornman DM, et al. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res. 1999;59:5119-5122.
98. Gazzeri S, Valle VD, Chaussade L, et al. The human p19ARF protein encoded by the beta transcript of the pl6INK4a gene is frequently lost in small cell lung cancer. Cancer Res. 1998;58:3926-3931.
99. Przygodzki RM, Finkelstein SD, Langer JC, et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors: correlation with histological tumors. Am J Pathol. 1996;148:1531-1541.
100. Kovatich A, Friedland DM, Druck T, et al. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors. Cancer. 1998;83:1109-1117.
101. Wang D-G, Johnston CF, Sloan JM, et al. Expression of bcl-2 in lung neuroendocrine tumours: comparison with p53. J Pathol. 1998;184:247-251.
102. Cagle PT, el-Naggar AK, Xu HJ, et al. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung: potential diagnostic implications Am J Pathol. 1997;150:393-400.
103. Rusch VW, Klimstra DS, Venkatraman ES. Molecular markers help characterize neuroendocrine lung tumors. Ann Thorac Surg. 1996;62:798-810.
104. Ito T, Udaka N, Okudela K, et al. Mechanisms of neuroendocrine differentiation in pulmonary neuroendocrine cells and small cell carcinoma. Endocr Pathol. 2003;14:133-139.